{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:15:47Z","timestamp":1785284147893,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Die intravitreale operative Medikamenteneingabe (IVOM) ist eine effiziente und risikoarme Applikationstechnik in der Behandlung unterschiedlicher Netzhauterkrankungen. Zu den seltenen schwerwiegenden Komplikationen z\u00e4hlen erh\u00f6hte Augeninnendr\u00fccke, Glask\u00f6rperblutungen, Netzhautrisse und -abl\u00f6sungen sowie intraokulare Entz\u00fcndungen und Endophthalmitiden. In der hier vorliegenden Fallserie berichten wir \u00fcber iatrogene Linsenverletzungen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methoden<\/jats:title>\n                <jats:p>Es erfolgte eine multizentrische Datenerhebung von IVOM-Patienten mit sichtbaren iatrogenen Linsendefekten, retrospektiv \u00fcber den Zeitraum 2016 bis 2023.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>In 6\u00a0F\u00e4llen (69,3 Jahre\u202f\u00b1\u20096,5) wurde ein Linsentrauma nach IVOM identifiziert. W\u00e4hrend in 5\u00a0F\u00e4llen eine Anti-VEGF-Therapie vorausgegangen war, stellten wir in einem Fall eine Linsenverletzung nach Dexamethason-Implantation fest.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerungen<\/jats:title>\n                <jats:p>Linsenverletzungen im Rahmen der IVOM sind eine seltene Komplikation und bei sachgem\u00e4\u00dfer Injektionstechnik vermeidbar. Kenntnisse \u00fcber die individuelle Bulbusachsenl\u00e4nge und den Linsenstatus tragen zus\u00e4tzlich zur Vermeidung dieser Komplikation bei.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00347-024-01997-8","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T11:02:39Z","timestamp":1708081359000},"page":"385-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Linsenverletzungen als Komplikation bei intravitrealer Medikamenteneingabe","Lens injury as a\u00a0complication of intravitreal medication injection"],"prefix":"10.1007","volume":"121","author":[{"given":"Christoph R.","family":"Clemens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Alten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Eter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"M\u00e4rker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"1997_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00347-021-01454-w","volume":"119","author":"C Wolfram","year":"2022","unstructured":"Wolfram\u00a0C, Schargus\u00a0M (2022) The Hamburg register for intravitreal injection therapies (QIVOM). Ophthalmologe 119:280\u2013287","journal-title":"Ophthalmologe"},{"key":"1997_CR2","first-page":"193","volume":"28","author":"M Wenzel","year":"2016","unstructured":"Wenzel\u00a0M, Auffarth\u00a0G, Scharrer\u00a0A et\u00a0al (2016) Intraokulare Operationen im Jahr 2015: Ergebnisse der aktuellen Umfrage von DGII, DOG, BVA und BDOC. OPHTHALMO-CHIRURGIE 28:193\u2013200","journal-title":"OPHTHALMO-CHIRURGIE"},{"key":"1997_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.oret.2020.09.024","volume":"5","author":"MS Ramos","year":"2021","unstructured":"Ramos\u00a0MS, Xu\u00a0LT, Singuri\u00a0S et\u00a0al (2021) Patient-reported complications after intravitreal injection and their predictive factors. Ophthalmol Retin 5:625\u2013632","journal-title":"Ophthalmol Retin"},{"key":"1997_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/ICU.0000000000000850","volume":"33","author":"D Patel","year":"2022","unstructured":"Patel\u00a0D, Patel\u00a0SN, Chaudhary\u00a0V, Garg\u00a0SJ (2022) Complications of intravitreal injections: 2022. Curr Opin Ophthalmol 33:137\u2013146","journal-title":"Curr Opin Ophthalmol"},{"key":"1997_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/jop.2010.0045","volume":"26","author":"CH Meyer","year":"2010","unstructured":"Meyer\u00a0CH, Rodrigues\u00a0EB, Michels\u00a0S et\u00a0al (2010) Incidence of damage to the crystalline lens during intravitreal injections. J\u00a0Ocul Pharmacol Ther 26:491\u2013495","journal-title":"J Ocul Pharmacol Ther"},{"key":"1997_CR6","first-page":"38","volume":"11","author":"B Baskan","year":"2016","unstructured":"Baskan\u00a0B, C\u0131cek\u00a0A, Gulhan\u00a0A et\u00a0al (2016) Ozurdex completely located inside a\u00a0crystallized lens - results of 14\u00a0months. Am J Ophthalmol 11:38\u201340","journal-title":"Am J Ophthalmol"},{"key":"1997_CR7","first-page":"112067212311749","volume":"10","author":"A Carnevali","year":"2023","unstructured":"Carnevali\u00a0A, Taloni\u00a0A, Gatti\u00a0V et\u00a0al (2023) Effect of intralenticular dexamethasone implant: a\u00a0case report. Eur J Ophthalmol 10:11206721231174934","journal-title":"Eur J Ophthalmol"},{"key":"1997_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000444163","volume":"7","author":"MA Sekeroglu","year":"2016","unstructured":"Sekeroglu\u00a0MA, Anayol\u00a0MA, Koc\u00a0F et\u00a0al (2016) Intralenticular sustained-release dexamethasone implant: is it still effective on macular edema? Case Rep Ophthalmol 7:85\u201389","journal-title":"Case Rep Ophthalmol"},{"key":"1997_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/eye.2014.18","volume":"28","author":"R Chhabra","year":"2014","unstructured":"Chhabra\u00a0R, Kopsidas\u00a0K, Mahmood\u00a0S (2014) Accidental insertion of dexamethasone implant into the crystalline lensd12 months follow-up. Eye 28:624\u2013625","journal-title":"Eye"},{"key":"1997_CR10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/eye.2014.192","volume":"28","author":"K Chalioulias","year":"2014","unstructured":"Chalioulias\u00a0K, Muqit\u00a0MM (2014) Vitreoretinal surgery for inadvertent intralenticular ozurdex implant. Eye 28:1523\u20131524","journal-title":"Eye"},{"key":"1997_CR11","first-page":"1","volume":"2020","author":"G Sborgia","year":"2020","unstructured":"Sborgia\u00a0G, Niro\u00a0A, D\u2019Oria\u00a0F et\u00a0al (2020) Surgical management of complications after dexamethasone implant. Case Rep Ophthalmol Med 2020:1\u20135","journal-title":"Case Rep Ophthalmol Med"},{"key":"1997_CR12","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown\u00a0DM, Kaiser\u00a0PK, Michels\u00a0M et\u00a0al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N\u00a0Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"1997_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld\u00a0PJ, Brown\u00a0DM, Heier\u00a0JS et\u00a0al (2006) Ranibizumab for neovascular age-related macular degeneration. New Engl J Med Med 355:1419\u20131431","journal-title":"New Engl J Med Med"},{"key":"1997_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000528657","volume":"246","author":"J Leite","year":"2023","unstructured":"Leite\u00a0J, Castro\u00a0C, Abreu\u00a0AC et\u00a0al (2023) Posterior capsular rupture during cataract surgery in eyes previously treated with intravitreal injections. Ophthalmologica 246:9\u201313","journal-title":"Ophthalmologica"},{"key":"1997_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000000047","author":"AM Nagar","year":"2020","unstructured":"Nagar\u00a0AM, Luis\u00a0J, Kainth\u00a0N et\u00a0al (2020) The risk of posterior capsule rupture during phacoemulsification cataract surgery in eyes with previous intravitreal anti vascular endothelial growth factor injections. J\u00a0Cataract Refract Surg. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000047","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1997_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000521576","volume":"65","author":"Z Zhong","year":"2022","unstructured":"Zhong\u00a0Z, He\u00a0Z, Yu\u00a0X et\u00a0al (2022) Intravitreal injection is associated with increased posterior capsule rupture risk during cataract surgery: a\u00a0meta analysis. Ophthalmic Res 65(2):152\u2013161","journal-title":"Ophthalmic Res"},{"issue":"6","key":"1997_CR17","first-page":"102533","volume":"24","author":"Y Li","year":"2021","unstructured":"Li\u00a0Y, Li\u00a0Z, Quan\u00a0Y et\u00a0al (2021) Macrophage recruitment in immune-privileged lens during capsule repair, necrotic fiberremoval, and fibrosis. Science 24(6):102533","journal-title":"Science"},{"issue":"7","key":"1997_CR18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.jcrs.2011.04.016","volume":"37","author":"YM Khalifa","year":"2011","unstructured":"Khalifa\u00a0YM, Pantanelli\u00a0SM (2011) Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon. J\u00a0Cataract Refract Surg 37(7):1364","journal-title":"J Cataract Refract Surg"},{"key":"1997_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2147\/OPTH.S103443","volume":"10","author":"JH Jun","year":"2016","unstructured":"Jun\u00a0JH, Sohn\u00a0WJ, Lee\u00a0Y et\u00a0al (2016) Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells. Clin Ophthalmol 10:1167\u20131174","journal-title":"Clin Ophthalmol"},{"key":"1997_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5301\/ejo.5000436","volume":"24","author":"A Berarducci","year":"2014","unstructured":"Berarducci\u00a0A, Sian\u00a0IS, Ling\u00a0R (2014) Inadvertent dexamethasone implant injection into the lens body management. Eur J Ophthalmol 24:620\u2013622","journal-title":"Eur J Ophthalmol"},{"key":"1997_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.5301\/ejo.5000439","volume":"24","author":"J Coca-Robinot","year":"2014","unstructured":"Coca-Robinot\u00a0J, Casco-Silva\u00a0B, Armad\u00e1-Maresca\u00a0F et\u00a0al (2014) Accidental injections of dexamethasone intravitreal implant (Ozurdex\u00ae) into the crystalline lens. Eur J Ophthalmol 24:633\u2013636","journal-title":"Eur J Ophthalmol"},{"key":"1997_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jcrs.2013.06.003","volume":"39","author":"M Munteanu","year":"2013","unstructured":"Munteanu\u00a0M, Rosca\u00a0C (2013) Repositioning and follow-up of intralenticular dexamethasone implant. J\u00a0Cataract Refract Surg 39:1271\u20131274","journal-title":"J Cataract Refract Surg"},{"key":"1997_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10792-017-0780-3","volume":"39","author":"R Clemente-Tom\u00e1s","year":"2017","unstructured":"Clemente-Tom\u00e1s\u00a0R, Hern\u00e1ndez-P\u00e9rez\u00a0D, Neira-Ib\u00e1\u00f1ez\u00a0P et\u00a0al (2017) Intracrystalline Ozurdex\u00ae therapeutic effect maintainedfor 18\u00a0months. Int Ophthalmol 39:207\u2013211","journal-title":"Int Ophthalmol"},{"key":"1997_CR24","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jcrs.2009.05.050","volume":"35","author":"MU Saeed","year":"2009","unstructured":"Saeed\u00a0MU, Prasad\u00a0S (2009) Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab. J\u00a0Cataract Refract Surg 35:1857\u20131859","journal-title":"J Cataract Refract Surg"},{"key":"1997_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/THC-160777","volume":"26","author":"A Karimi","year":"2018","unstructured":"Karimi\u00a0A, Razaghi\u00a0R, Biglari\u00a0H (2018) A comparative study to determine the optimal intravitreal injection angle to the eye: a\u00a0computational fluid-structure interaction model. Technol Health Care 26:483\u2013498","journal-title":"Technol Health Care"},{"key":"1997_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/IAE.0b013e3181b094cf","volume":"30","author":"JP Hubschman","year":"2010","unstructured":"Hubschman\u00a0JP, Coffee\u00a0RE, Bourges\u00a0JL et\u00a0al (2010) Experimental model of intravitreal injection techniques. Retina 30:167\u2013173","journal-title":"Retina"},{"key":"1997_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","volume":"239","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski\u00a0A, Told\u00a0R, Sacu\u00a0S et\u00a0al (2018) Update on Intravitreal Injections: Euretina Expert Consensus Recommendations. Ophthalmologica 239:181\u2013193","journal-title":"Ophthalmologica"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-01997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-01997-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-01997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:03:51Z","timestamp":1723215831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-01997-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-01997-8","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.R.\u00a0Clemens, F.\u00a0Alten, N.\u00a0Eter, H.\u00a0Helbig und D.A.\u00a0M\u00e4rker geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}